PharmAsia Newsmaker Documents: Landmark Bayer IP Decision In India
This article was originally published in PharmAsia News
Executive Summary
In a new periodic feature, PharmAsia News highlights key regulatory and legal documents impacting biopharma and medical device companies doing business in Asia.